Revolution Medicines (RVMD) Net Equity Issued and Repurchased (2019 - 2026)
Revolution Medicines (RVMD) posted Net Equity Issued and Repurchased of $141.9 million for Q2 2026, little changed on a QoQ basis from $141.9 million in Q1 2026.
Powered by 
Analysis
Revolution Medicines (RVMD) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
Revolution Medicines has reported Net Equity Issued and Repurchased for 7 years, with the latest figure at $141.9 million in Q2 2026.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $141.9 million in Q2 2026; TTM through Jun 2026 was $1.0 billion, a N/A change from a year earlier, with the FY2024 full-year figure at $727.6 million, up 124.78% from the prior year.
- Net Equity Issued and Repurchased was $141.9 million for Q2 2026 at Revolution Medicines, roughly flat from $141.9 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $727.6 million in Q4 2024, with the low at $62.1 million in Q2 2023.
- Average Net Equity Issued and Repurchased over 4 years is $274.2 million, with a median of $195.0 million recorded in 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | - |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | - |
| 10 | Revolution Medicines | 40.86 Bn | 40.86 Bn | - | 141.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 141.90 Mn |
| Mar 31, 2026 | 141.90 Mn |
| Dec 31, 2024 | 727.62 Mn |
| Jun 30, 2023 | 62.10 Mn |
| Mar 31, 2023 | 323.70 Mn |
| Sep 30, 2022 | 248.13 Mn |
| Jun 30, 2021 | -564,000.00 |
| Mar 31, 2021 | 281.71 Mn |
| Dec 31, 2020 | -34,000.00 |
| Sep 30, 2020 | 167.80 Mn |
| Jun 30, 2020 | -1.42 Mn |
| Mar 31, 2020 | 253.72 Mn |
| Dec 31, 2019 | -5,000.00 |
| Sep 30, 2019 | 9.86 Mn |
| Jun 30, 2019 | 90.16 Mn |
| Mar 31, 2019 | 14,000.00 |
API Access
Revolution Medicines Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();